nanose medical
General Data
Reg Number
516096187
Sector
Biomed
Established
2019
No. of Employees
10
Stage
R&D
Additional Funding
1
Description
A game-changer in non-invasive diagnostics. Breakthrough AI Driven Sensing Technology for Disease Screening and Management at Early Stages Using Breath Biomarkers
Technology
A coronavirus diagnosing system that uses nanotechnology to identify specific volatile organic compounds (VOCs) from the lung that are in the exhaled breath of coronavirus patients.
Targeted Customers
Physicians.
Management personnel
Winning details
Route name
Winning year
The Expedited Program
The Expedited Program
2024
R&D Fund
R&D Fund
2025